D Bentué-Ferrer

Author PubWeight™ 11.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adrenal medulla responsiveness to the sympathetic nervous activity in sprinters and untrained subjects during a supramaximal exercise. Int J Sports Med 1998 0.88
2 Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. Eur J Pharmacol 1998 0.86
3 Assessment of interindividual variability of plasma concentrations after administrazion of high doses of intravenous amoxicillin or cloxacillin in critically ill patients. J Chemother 2011 0.82
4 Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers. Psychopharmacology (Berl) 2002 0.82
5 Effect of training and detraining on catecholamine responses to sprint exercise in adolescent girls. Eur J Appl Physiol 2006 0.80
6 Lisuride prevents learning and memory impairment and attenuates the increase in extracellular dopamine induced by transient global cerebral ischemia in rats. Brain Res 1997 0.79
7 Potential biological targets for anti-Alzheimer drugs. Dementia 1994 0.79
8 Pharmacological strategies in the treatment of cerebral ischemia. Eur Neurol 1995 0.79
9 Effects of nicardipine and clonidine on cognitive functions and electroencephalography in hypertensive patients. Fundam Clin Pharmacol 2002 0.78
10 Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease. The French Lisuride Study Group. Eur Neurol 2000 0.78
11 Aminergic neurotransmitter and water content changes in rats after transient forebrain ischemia. J Neurochem 1986 0.77
12 Clinical efficacy of almitrine-raubasine. An overview. Eur Neurol 1998 0.76
13 Effect of training status on the sympathoadrenal activity during a supramaximal exercise in human. J Sports Med Phys Fitness 2001 0.76
14 Experimental and clinical methods in the development of anti-Alzheimer drugs. Fundam Clin Pharmacol 1998 0.76
15 [Prescription of olanzapine in children and adolescent psychiatric patients]. Encephale 2007 0.75
16 Training status (endurance or sprint) and catecholamine response to the Wingate-test in women. Int J Sports Med 2002 0.75
17 Monoamine oxidase inhibitors, cognitive functions and neurodegenerative diseases. J Neural Transm Suppl 1994 0.75
18 [Beta interferon in multiple sclerosis: pharmacological differences]. Rev Neurol (Paris) 1999 0.75
19 [NOEMIE: an epidemiological study of migraine at work: results from 17 occupational health centres]. Rev Neurol (Paris) 2004 0.75
20 [Pharmacology of central cholinergic synapse]. Rev Med Interne 1988 0.75
21 [Anti-cerebral edema properties of PEG 300 in triethyltin poisoning]. J Pharmacol 1987 0.75
22 Is chlormethiazole neuroprotective in experimental global cerebral ischemia? A microdialysis and behavioral study. Pharmacol Biochem Behav 1997 0.75
23 [Calcium antagonists and the central nervous system]. Therapie 1994 0.75
24 [Effect of almitrine/raubasine on cerebral metabolism in the elderly]. Presse Med 2002 0.75
25 Alteration of aminergic neurotransmitter release after two consecutive transient global ischaemias: an in vivo microdialysis study in rat. Neurol Res 1993 0.75
26 [Adverse effects and drugs for Alzheimer's disease]. Therapie 1999 0.75
27 [Drug distribution systems in hospitals]. Therapie 2002 0.75
28 Comparison of the influence of dihydroergotoxine on cerebral oxygenation in the normoxic and hypercapnic hypoxic dog. J Pharmacol 1985 0.75
29 [Myoclonic encephalopathy associated with proton pump inhibitors]. Rev Neurol (Paris) 2004 0.75
30 Effect of brain microdialysis on aminergic transmitter levels in repeated cerebral global transient ischemia in rat. J Neurosci Methods 1996 0.75
31 Choosing a target for cognitive enhancers. Clin Ther 1990 0.75
32 [Parkinson disease: interrogations and solutions]. Presse Med 1997 0.75
33 [Hydroxylation of debrisoquin in Parkinson's disease]. Presse Med 1990 0.75
34 [The physiopathology of migraine]. Pathol Biol (Paris) 2000 0.75
35 [Modification of aminergic neurotransmitters and neurobehavioral correlates in acute cerebral ischemia in the rat]. J Pharmacol 1987 0.75